Tuesday, October 21, 2025
12:00PM – 1:00PM ET
Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PRESENTING FACULTY
 |
Tim Feyma, MD Co-Director, Complex Movement Disorder Clinic and Principal Investigator, Rett Syndrome Clinical Trials (including gene therapy) Gillette Children’s Specialty Healthcare Consultant Neurologist, Noran Neurology Clinic, Gillette Children’s Specialty Healthcare, and Minneapolis Children’s Hospital Member, Research Advisory Board, International Rett Syndrome Foundation Minneapolis, Minnesota |
PROGRAM OVERVIEW
This online interactive educational series aims to review and apply treatment strategies for patients living with Rett syndrome. Presentations and animations review the Rett patient and caregiver journey and the latest clinical data on approved and emerging therapies. Case discussions aim to help clinicians evaluate optimal treatment regimens to improve and manage symptoms of individual patients and involve caregivers in treatment decision process.
TARGET AUDIENCE
This activity is intended for pediatric neurologists, neurologists, neurology nurses, NPs, and PAs involved in the diagnosis and treatment of RTT.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Create strategies to align provider and caregiver perceptions regarding the efficacy of RTT treatment and its impact on quality of life
- Analyze clinical trial results evaluating new therapeutic options for RTT
- Integrate shared SDM with caregivers into routine clinical practice for RTT management
- Develop individualized treatment plans that identify and address family and caregiver burden
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
ACCME INNOVATIVE PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, dietary, physical, etc). Please contact Med Learning Group prior to participating at [email protected]
